Back to top

Share Transfer and Capital Increase Agreement

Stock Transfer Agreement

Share Transfer and Capital Increase Agreement | Document Parties: Beijing Med-Pharm Corporation | Shanghai Rongheng International Trade Co, Ltd | Shanghai Rongheng Pharmaceutical Co Ltd You are currently viewing:
This Stock Transfer Agreement involves

Beijing Med-Pharm Corporation | Shanghai Rongheng International Trade Co, Ltd | Shanghai Rongheng Pharmaceutical Co Ltd

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: Share Transfer and Capital Increase Agreement
Governing Law: Delaware     Date: 3/21/2007
Industry: Biotechnology and Drugs     Sector: Healthcare

Share Transfer and Capital Increase Agreement, Parties: beijing med-pharm corporation , shanghai rongheng international trade co  ltd , shanghai rongheng pharmaceutical co ltd
50 of the Top 250 law firms use our Products every day
 

Exhibit 2.1

Share Transfer and Capital Increase Agreement

Related to

Shanghai Rongheng Pharmaceutical Co. Ltd.

Among

Shanghai CAS Shenglongda Biotech (Group) Co., Ltd
Shanghai Rongheng International Trade Co., Ltd. of
Orient International (Holding) Co.
Yiliang Lou

And

Beijing Med-Pharm Corporation

Date: Mar 15 , 2007

 


 

Share Transfer and Capital Increase Agreement

This Share Transfer and Capital Increase Agreement (this “ Agreement ”) is made in Shanghai on Mar 15, 2007 by and among:

(1)

 

Shanghai CAS Shenglongda Biotech (Group) Co., Ltd (“ Shenglongda ”), a company duly incorporated and legally existing under the law of the People’s Repubilc of China (the “PRC”), with its legal address at Room 208, No. 6649, Chuanbei Road, Pudong New District, legal representative being Gao Xiang;

 

 

 

(2)

 

Shanghai Rongheng International Trade Co., Ltd. of Orient International (Holding) Co. (“RHIT” ), a company duly incorporated and legally existing under the law of the PRC, with its legal address at 2-3 floors, Xiao Cheng Lu No. 58, Pudong New District, legal representative being Zhou Jun;

 

 

 

(3)

 

Y iliang Lou, with the number of his identity card being [                                          ]; and

 

 

 

(4)

 

Beijing Med-Pharm Corporation (“ BMP ”), a corporation incorporated under the law of the State of Delaware, the United States, with its domicile at 600 W. Germantown Pike, Suite 400 Plymouth Meeting, PA, legal representative being Xiaoying Gao (Title: Chief Executive Officer and President; Nationality: USA).

Shenglongda, RHIT, Yiliang Lou and BMP hereinafter collectively referred to as the “ Parties ”.

Recitals

(1)

 

Whereas, Shanghai Rongheng Pharmaceutical Co. Ltd. (the “ Company ”) is a limited liability company duly incorporated under the law of the PRC, with its registered capital being RMB 10 million, among which Shenglongda holds 60% of its equity interests, RHIT holds 30%, and Yiliang Lou holds 10%. For the purpose of this Agreement, Shenglongda, RHIT and Yiliang Lou shall be collectively referred to as the “ Existing Shareholders ”;

(2)

 

Whereas, the Existing Shareholders unanimously agree that BMP may obtain 63.33% of the equity interests of the Company by acquiring 45% of the equity interest held by Shenglongda therein and further subscribing the RMB5 million increased capital of the Company; and BMP wishes to acquire 63.33% of the equity interests of the Company through the above approaches;

 

(3)

 

Whereas, with respect to the share transfer and capital increase set out in above

 


 

 

 

 

 

(2), Shenglongda has carried out state-owned assets appraisal and has obtained approval from China Academy of Science, the state-owned assets administration authority. Shenglongda has posted the share transfer at Shanghai Lianhe Equity Exchange and BMP has become the transferee of such shares. Shanghai Lianhe Equity Exchange has issued Shenglongda Closing Notice on Equity Transfer;

 

(4)

 

Whereas, with respect to the capital increase through the approaches set out in above (2), RHIT has carried out state-owned assets appraisal and has obtained approval from Orient International (Holding) Co, the state-owned assets administration authority;

(5)

 

Whereas, the Company has reported to the employees’ representative meeting in respect of the restructuring of the Company with the participation of foreign investment through means set out in above (2).

Therefore, the Existing Shareholders and BMP reach the following agreement:

Article 1 Share Transfer and Capital Increase

1.1

 

The Existing Shareholders and BMP agree to transfer the equity interest and increase the capital of the Company as follows:

 

(1)

 

Shenglongda agrees to transfer to BMP 45% of the equity interest of the Company it holds.

 

 

 

 

 

 

 

RHIT and Yiliang Lou hereby waiver their respective pre-emption right to the above transferred equity interest.

 

 

 

 

 

(2)

 

While Shenglongda transfers its equity interest as per above (1), the Existing Shareholders agree that the registered capital of the Company shall be increased to RMB 15 million from RMB 10 million. The amount of the increased capital is RMB 5 million (the “ Amount of Increased Capital ”). BMP agrees to subscribe the Amount of Increased Capital. The Existing Shareholders waive their respective pre-emption right to the Amount of Increase Capital.

 

 

 

 

 

(3)

 

Upon the completion of the above share transfer and capital increase, the share structure of the Company shall be as follows:

 

 

 

 

 

 

 

 

 

 

BMP

 

 

63.33

%

 

 

Shenglongda

 

 

10

%

 

 

RHIT

 

 

20

%

- 1 -


 

 

 

 

 

 

 

 

 

 

Yiliang Lou

 

 

6.67

%

 

1.2

 

Within five (5) working days after the date hereof, the parties shall cause the Company to submit this Agreement together with other necessary application documents to the Ministry of Commerce or its authorized authority (the “ Examination and Approval Authority ”).

1.3

 

The Parties shall take their best endeavour to obtain the approval from the Examination and Approval Authority, to assist the Company in going through the amendment registration formalities with Shanghai Administration for Industry and Commerce (the “ Registration Authority ”) and to obtain other government approval, verification or registration which are required for the purpose of implementing the share transfer and capital increase hereunder.

Article 2 Payment of the Transfer Price and the Amount of Increased Capital

2.1

 

The Parties agree that when part or all of the following conditions have been fully satisfied (depending on the situations provided under Articles 2.2 and 2.3), BMP shall perform its payment obligation set out in Articles 2.2 and 2.3 hereunder:

 

(1)

 

With respect to the share transfer and capital increase provided herein, Shenglongda has obtained approval from the state-owned assets administration authority and has posted the share transfer at Shanghai Lianhe Equity Exchange and BMP has become the transferee of the transferred shares. The Closing Notice on Equity Transfer is attached hereto as Schedule 1;

 

 

 

 

 

(2)

 

With respect to the capital increase provided herein, RHIT has obtained approval from the state-owned assets administration authority;

 

 

 

 

 

(3)

 

The share transfer and capital increase contemplated under this Agreement, the Joint Venture Agreement entered into by and among BMP and the Existing Shareholders, and the revised and restated Articles of Association of the Company have been approved by the Examination and Approval Authority and the Company has been issued with the relevant approval reply and the Approval Certificate of Foreign Investment Enterprise;

 

 

 

 

 

(4)

 

The share transfer and capital increase contemplated under this Agreement,

- 2 -


 

 

 

 

the Joint Venture Agreement entered into by and among BMP and the Existing Shareholders, and the revised Articles of Association of the Company have been effected with Shanghai Administration for Industry and Commerce (the “ Registration Authority ”). The Company has received the revised Business License;

 

 

 

 

 

(5)

 

The Company has completed the foreign exchange registration and has opened foreign exchange capital account; and

 

 

 

 

 

(6)

 

There shall have been no material adverse change (including any undisclosed indebtedness) in the financial condition, operations or business prospects of the Company from the base date set out in the appraisal report submitted by Shenglongda and RHIT for the share transfer and capital increase hereunder till the expiration of the Transition Period defined in Article 4.1, with the exception of any such change resulting from an action or inaction taken by the Company with the approval of the Supervision Committee defined in Article 4.1. For the purpose of this Agreement, material adverse change means the reduced amount of the net assets of the Company exceeds 15% (inclusive) of the net assets determined in the above-mentioned appraisal report.

2.2

 

Subject to the satisfaction of each and every conditions set out in Article 2.1 (with the exception of Article 2.1(4)), BMP shall input the Amount of Increased Capital into the Company in RMB in a lump sum when the Company applies for the revised Business License;

 

2.3

 

The Parties agree that, with respect to the share transfer set out in Article 1.1(1), subject to the satisfaction of each and every conditions set out in Article 2.1, BMP shall pay Shenglongda RMB 6 million or other amount adjusted as per the sub-section of this Article 2.3 as the share transfer price (the “ Transfer Price ”) the Company obtains the revised Business License, including an amount equal to the Warranty Deposit as provided under Article 2.4.

 

 

 

If the condition set out in Article 2.1(6) is not satisfied on the day when the Company obtains the revised Business License, BMP shall have the option to choose to:

 

 

(1)

 

terminate this Agreement; or

 

 

 

 

 

(2)

 

continue to perform this Agreement. However, the Transfer Price shall be reduced by an amount equivalent to the portion of the reduced amount to

- 3 -


 

 

 

 

the net assets of the Company calculated by the percentage of the acquired equity interests. Where the adjusted amount caused by such adverse change, which shall be determined by the appraisal result issued by mutually recognized appraiser, has not been determined prior to the time when BMP is obliged to make the payment, the Parties agree that the payment term shall be extended accordingly.

2.4

 

After BMP becomes the transferee during the course of the posting process and within 5 working days after the execution of this Agreement, BMP shall apply to Shanghai Lianhe Equity Exchange for opening of an warranty account for an amount equivalent to RMB 1.2 million (“ Warranty Deposit ”) and BMP and Shenglongda shall sign necessary document with Shanghai Lianhe Equity Exchange for effecting such account.

 

 

 

 

 

Upon the satisfaction of each and every condition set out in Article 2.1 and subject to the verification of relevant administration of foreign exchange, the Warranty Deposit will be paid to Shenglongda as part of the Transfer Price in accordance with Article 2.3.

 

 

 

 

 

If any condition set out in Article 2.1 is not satisfied prior to the expiration of the warranty account, Shenglongda shall assist BMP to go through the procedures as to the remittance of the Warranty Deposit abroad unless the Parties have agreed to continue to perform this Agreement. Where the Parties agree to continue to perform this Agreement, BMP shall apply to relevant administration of foreign exchange for the renewal of the warranty account.

 

 

 

2.5

 

BMP shall make payment to Shenglongda in accordance with Article 2.3 in equivalent US dollars amount calculated at the average rate between US dollars and RMB promulgated by the People’s Bank of China on the date of payment. Shenglongda shall notify BMP in writing of its bank account to receive such payment and the payment itinerary in advance and shall take all necessary actions to assist BMP in going through relevant foreign exchange registration.

 

 

 

2.6

 

The Existing Shareholders agree and acknowledge that BMP shall have no payment obligations towards the Existing Shareholders for its acquisition of the 63.33% equity interests of the Company except for those expressly provided herein.

Article 3 Settlement of Indebtedness of the Company

3.1

 

BMP, Shenglongda and RHIT agree that after the completion of the share transfer and capital increase provided herein, it will assist the Company to solve the

- 4 -


 

 

 

 

 

funding required for the future development of the Company as per its equity percentage.

 

3.2

 

With respect to the following indebtedness of the Company, based on the principal of “first lending, first repaid”, the Parties hereby agree to the arrangement as follows:

 

(1)

 

As of the date hereof, Shenglongda has advanced RMB 2.65 million to the Company. The Company shall repay such facility no later than three years after the completion of the share transfer and capital increase provided herein.

 

 

 

 

 

(2)

 

As of the date hereof, a subsidiary of RHIT, has advanced RMB 9.4 million t


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more